Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT04382040
Brief Title: A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19

First Submitted : May 7, 2020
First Submitted that Met QC Criteria : May 7, 2020
First Posted : May 11, 2020

Last Update Submitted that Met QC Criteria : August 25, 2021
Last Update Posted : August 31, 2021